Table 4 Response to treatment: T/N down-staging and TRG
pT0 | pT1 | pT2 | pT3 | pT4 | Total, n (%) | |
cT2 | 2 | 0 | 1 | 0 | 0 | 3 (4.2) |
cT3 | 17 | 8 | 17 | 19 | 0 | 61 (84.7) |
cT4 | 1 | 0 | 2 | 4 | 1 | 8 (11.1) |
Total, n (%) | 20 (27.8) | 8 (11.1) | 20 (27.8) | 23 (31.9) | 1 (1.4) | 72 (100) |
pN0 | pN1 | pN2 | pNxa | Total, n (%) | ||
cN0 | 7 | 2 | 1 | 2 | 12 (16.7) | |
cN1 | 22 | 9 | 1 | 5 | 37 (51.4) | |
cN2 | 19 | 2 | 1 | 1 | 23 (31.9) | |
Total, n (%) | 48 (66.7) | 13 (18.1) | 3 (4.2) | 8 (11.1) | 72 (100) | |
TRG1 | TRG2 | TRG3 | TRG4 | TRG5 | Total, n (%) | |
cT2 | 2 | 1 | 0 | 0 | 0 | 3 (4.2) |
cT3 | 17 | 21 | 21 | 2 | 0 | 61 (84.7) |
cT4 | 1 | 4 | 3 | 0 | 0 | 8 (11.1) |
Total, n (%) | 20 (27.8) | 26 (36.1) | 24 (33.3) | 2 (2.8) | 0 (0) | 72 (100) |